Vancomycin intermediate and vancomycin resistant staphylococcus aureus - mechanisms, clinical significance, and detection

Jyoti Kumari, Shalini M. Shenoy, Ashwini Hegde, K. Vidyalakshmi, M. Chakrapani, Gopalkrishna K. Bhat*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Vancomycin is used as the antibiotic of choice for severe infection caused by methicillin-resistant Staphylococcus aureus. Increased use of vancomycin and the selective pressure has resulted in the emergence of S. aureus with reduced susceptibility to vancomycin and vancomycin-resistant S. aureus. This review summarizes the definition, mechanism, clinical significance, and epidemiology of S. aureus with reduced susceptibility to vancomycin. It also discusses laboratory methods for detection and treatment options available for these pathogens.

Original languageEnglish
Pages (from-to)32-38
Number of pages7
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume10
Issue number6
DOIs
Publication statusPublished - 2017

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Vancomycin intermediate and vancomycin resistant staphylococcus aureus - mechanisms, clinical significance, and detection'. Together they form a unique fingerprint.

Cite this